Intellectual Property India Publishes Patent Application for A Treatment For Patients With Mood Disorders Using N-Ethyl-2-(5-Fluoro-1h-Indol-3-Yl)- N- Methylethan-1-Amine Or A Pharmaceutically Acceptable Salt Thereof

MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202647074996 A) filed by Gilgamesh Pharmaceuticals, Inc. on June 17, 2026, for A Treatment For Patients With Mood Disorders Using N-Ethyl-2-(5-Fluoro-1h-Indol-3-Yl)- N- Methylethan-1-Amine Or A Pharmaceutically Acceptable Salt Thereof.

Inventors include Kruegel, Andrew Carry; Marek, Gerard Joseph; and Hughes, Zoe A..

The application for the patent was published on June 26, 2026, under issue no. 26/2026.

Abstract: The present disclosure relates to a method of treating a patient having a mood disorder comprising administering to a subject in need thereof a pharmaceutical composition comprising a base compound comprising substantially pure N-ethyl-2-(5...